Cargando…
Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review
The Acute Respiratory Distress Syndrome (ARDS) is a devastating clinical condition that is associated with a 30–40% risk of death, and significant long term morbidity for those who survive. Mesenchymal stromal cells (MSC) have emerged as a potential novel treatment as in pre-clinical models they hav...
Autores principales: | McIntyre, Lauralyn A., Moher, David, Fergusson, Dean A., Sullivan, Katrina J., Mei, Shirley H. J., Lalu, Manoj, Marshall, John, Mcleod, Malcolm, Griffin, Gilly, Grimshaw, Jeremy, Turgeon, Alexis, Avey, Marc T., Rudnicki, Michael A., Jazi, Mazen, Fishman, Jason, Stewart, Duncan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731557/ https://www.ncbi.nlm.nih.gov/pubmed/26821255 http://dx.doi.org/10.1371/journal.pone.0147170 |
Ejemplares similares
-
The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research
por: Avey, Marc T., et al.
Publicado: (2016) -
Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol
por: Lalu, Manoj M, et al.
Publicado: (2014) -
Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
por: Lalu, Manoj M, et al.
Publicado: (2016) -
Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol
por: Barron, Carly C., et al.
Publicado: (2017) -
Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol
por: Suen, Colin M., et al.
Publicado: (2016)